In a mouse model of breast cancer, the COX-2 inhibitor celecoxib
(Celebrex) prevents chronic morphine-induced effects on tumor
growth without compromising pain relief, scientists report.
In a mouse model of breast cancer, the COX-2 inhibitor celecoxib
(Celebrex) prevents chronic morphine-induced effects on tumor
growth without compromising pain relief, scientists report.